
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease
Luca Magistrelli, Elena Contaldi, Cristoforo Comi
Life (2021) Vol. 11, Iss. 8, pp. 804-804
Open Access | Times Cited: 36
Luca Magistrelli, Elena Contaldi, Cristoforo Comi
Life (2021) Vol. 11, Iss. 8, pp. 804-804
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis
Viviana A. Ruiz‐Pozo, Rafael Tamayo‐Trujillo, Santiago Cadena-Ullauri, et al.
Nutrients (2023) Vol. 15, Iss. 16, pp. 3585-3585
Open Access | Times Cited: 28
Viviana A. Ruiz‐Pozo, Rafael Tamayo‐Trujillo, Santiago Cadena-Ullauri, et al.
Nutrients (2023) Vol. 15, Iss. 16, pp. 3585-3585
Open Access | Times Cited: 28
Evolving Landscape of Parkinson’s Disease Research: Challenges and Perspectives
Rumiana Koynova, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Omega (2025) Vol. 10, Iss. 2, pp. 1864-1892
Open Access | Times Cited: 1
Rumiana Koynova, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Omega (2025) Vol. 10, Iss. 2, pp. 1864-1892
Open Access | Times Cited: 1
NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson's disease
Mayuri Khot, Anika Sood, Kamatham Pushpa Tryphena, et al.
European Journal of Pharmacology (2022) Vol. 934, pp. 175300-175300
Closed Access | Times Cited: 33
Mayuri Khot, Anika Sood, Kamatham Pushpa Tryphena, et al.
European Journal of Pharmacology (2022) Vol. 934, pp. 175300-175300
Closed Access | Times Cited: 33
Altered neural cell junctions and ion-channels leading to disrupted neuron communication in Parkinson’s disease
Saptamita Paul Choudhury, Sarika Bano, Srijon Sen, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 31
Saptamita Paul Choudhury, Sarika Bano, Srijon Sen, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 31
Cyclic Ion Mobility-Mass Spectrometry and Tandem Collision Induced Unfolding for Quantification of Elusive Protein Biomarkers
Devin M. Makey, Varun V. Gadkari, Robert T. Kennedy, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 15, pp. 6021-6029
Open Access | Times Cited: 6
Devin M. Makey, Varun V. Gadkari, Robert T. Kennedy, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 15, pp. 6021-6029
Open Access | Times Cited: 6
Application of Nanobiosensor Engineering in the Diagnosis of Neurodegenerative Disorders
Thikra S. Dhahi, Alaa Kamal Yousif Dafhalla, A. Wesam Al-Mufti, et al.
Results in Engineering (2024) Vol. 24, pp. 102790-102790
Open Access | Times Cited: 6
Thikra S. Dhahi, Alaa Kamal Yousif Dafhalla, A. Wesam Al-Mufti, et al.
Results in Engineering (2024) Vol. 24, pp. 102790-102790
Open Access | Times Cited: 6
Disease modification in Parkinsonism: obstacles and ways forward
Matthias Höllerhage, Martin Klietz, Günter U. Höglinger
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1133-1153
Open Access | Times Cited: 23
Matthias Höllerhage, Martin Klietz, Günter U. Höglinger
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1133-1153
Open Access | Times Cited: 23
The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington’s Disease
Shahnawaz Ali Bhat, Shakir Ahamad, Nawab John Dar, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 4, pp. 867-889
Open Access | Times Cited: 14
Shahnawaz Ali Bhat, Shakir Ahamad, Nawab John Dar, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 4, pp. 867-889
Open Access | Times Cited: 14
Unraveling neuroprotection in Parkinson’s disease: Nrf2–Keap1 pathway’s vital role amidst pathogenic pathways
Tanzeer Kaur, Palak Sidana, Navpreet Kaur, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2801-2820
Closed Access | Times Cited: 5
Tanzeer Kaur, Palak Sidana, Navpreet Kaur, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2801-2820
Closed Access | Times Cited: 5
Non-motor symptoms of Parkinson`s disease-insights from genetics
Kristina Gotovac, Antonela Blažeković, Sabina Borovečki, et al.
Journal of Neural Transmission (2024)
Closed Access | Times Cited: 5
Kristina Gotovac, Antonela Blažeković, Sabina Borovečki, et al.
Journal of Neural Transmission (2024)
Closed Access | Times Cited: 5
Genetic mutations in kinases: a comprehensive review on marketed inhibitors and unexplored targets in Parkinson's disease
Amir Raza, Jeevika Raina, Sanjeev Kumar Sahu, et al.
Neurological Sciences (2025)
Closed Access
Amir Raza, Jeevika Raina, Sanjeev Kumar Sahu, et al.
Neurological Sciences (2025)
Closed Access
Aberrant expression of long noncoding RNAs regulates inflammasome activation via oxidative stress: A novel mechanism for neuroinflammation and neurodegeneration in Parkinson's disease
Irene Mary Praveen, Calivarathan Latchoumycandane
Clinical and Experimental Neuroimmunology (2025)
Closed Access
Irene Mary Praveen, Calivarathan Latchoumycandane
Clinical and Experimental Neuroimmunology (2025)
Closed Access
Muscle Matters: Transforming Amyotrophic Lateral Sclerosis Diagnostics with Next-Gen Biosensors and Smart Detection
Saumitra Singh, Sameer Khan, Shahbaz Khan, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Saumitra Singh, Sameer Khan, Shahbaz Khan, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Advances in autonomic dysfunction research in Parkinson’s disease
Huichun Xu, Xiaolei Zheng, Xinyue Xing, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Huichun Xu, Xiaolei Zheng, Xinyue Xing, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Parkinson’s Disease: Biomarkers for Diagnosis and Disease Progression
Rakesh Arya, A. K. M. Ariful Haque, Hemlata Shakya, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12379-12379
Open Access | Times Cited: 4
Rakesh Arya, A. K. M. Ariful Haque, Hemlata Shakya, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12379-12379
Open Access | Times Cited: 4
Classification of Parkinson’s disease with and without dopaminergic deficiency based on non-motor symptoms and structural neuroimaging
Lucas Ronat, Pierre Rainville, Oury Monchi, et al.
Neurological Sciences (2025)
Closed Access
Lucas Ronat, Pierre Rainville, Oury Monchi, et al.
Neurological Sciences (2025)
Closed Access
Recent Advances in the Treatment of Genetic Forms of Parkinson’s Disease: Hype or Hope?
Francesco Cavallieri, Rubens Gisbert Cury, Thiago Gonçalves Guimarães, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 764-764
Open Access | Times Cited: 10
Francesco Cavallieri, Rubens Gisbert Cury, Thiago Gonçalves Guimarães, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 764-764
Open Access | Times Cited: 10
Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?
Bradley Roberts, Frances Theunissen, Francis Mastaglia, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9364-9364
Open Access | Times Cited: 14
Bradley Roberts, Frances Theunissen, Francis Mastaglia, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9364-9364
Open Access | Times Cited: 14
Systematic analysis of multi-omics data reveals component-specific blood-based biomarkers for Parkinson’s disease
Tng J. W. Teddy, Barbara Wing Yan Wong, Esther H. Y. Sim, et al.
Translational Medicine Communications (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Tng J. W. Teddy, Barbara Wing Yan Wong, Esther H. Y. Sim, et al.
Translational Medicine Communications (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: mutations, propagation, aggregation, and the formation of inclusions
Armin Bayati, Peter S. McPherson
Journal of Biological Chemistry (2024) Vol. 300, Iss. 10, pp. 107742-107742
Open Access | Times Cited: 2
Armin Bayati, Peter S. McPherson
Journal of Biological Chemistry (2024) Vol. 300, Iss. 10, pp. 107742-107742
Open Access | Times Cited: 2
Retinal Changes in Parkinson’s Disease: A Non-invasive Biomarker for Early Diagnosis
Mohana Devi Subramaniam, P. Aishwarya Janaki, Abishek Kumar, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 8, pp. 3983-3996
Closed Access | Times Cited: 6
Mohana Devi Subramaniam, P. Aishwarya Janaki, Abishek Kumar, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 8, pp. 3983-3996
Closed Access | Times Cited: 6
Demystifying the Neuroprotective Role of Neuropeptides in Parkinson’s Disease: A Newfangled and Eloquent Therapeutic Perspective
Tapan Behl, Piyush Madaan, Aayush Sehgal, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4565-4565
Open Access | Times Cited: 10
Tapan Behl, Piyush Madaan, Aayush Sehgal, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4565-4565
Open Access | Times Cited: 10
Cyclic Ion Mobility-Mass Spectrometry and Tandem Collision Induced Unfolding for Quantification of Elusive Protein Biomarkers
Devin M. Makey, Varun V. Gadkari, Robert T. Kennedy, et al.
(2024)
Open Access | Times Cited: 1
Devin M. Makey, Varun V. Gadkari, Robert T. Kennedy, et al.
(2024)
Open Access | Times Cited: 1
SNCA is a potential therapeutic target for COVID-19 infection in diffuse large B-cell lymphoma patients
Can Chen, Yun Li, Yiwei Li, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1454-1465
Open Access | Times Cited: 1
Can Chen, Yun Li, Yiwei Li, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1454-1465
Open Access | Times Cited: 1
The RAB32 p.Ser71Arg Variant in Parkinsonisms: Insights from a Large Italian Cohort
Luca Magistrelli, Marta Benedetta Brumana, Valeria Rimoldi, et al.
Movement Disorders (2024)
Open Access | Times Cited: 1
Luca Magistrelli, Marta Benedetta Brumana, Valeria Rimoldi, et al.
Movement Disorders (2024)
Open Access | Times Cited: 1